Article

Flexible RSV prefusogenic fusion glycoprotein exposes multiple neutralizing epitopes that may collectively contribute to protective immunity

2020-09-14

Abstract excerpt

Human respiratory syncytial virus (RSV) is a significant cause of lower respiratory tract infection in infants, young children, and older adults. There is no licensed vaccine and prophylactic treatment options are limited and not widely available in developing countries with the greatest disease burden. The RSV fusion (F) glycoprotein is a primary target of host immunity and thus a major focus for vaccine developm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 79fdae98-7ef1-5718-b98d-7b28e6283e58
DOI: 10.1101/2020.09.14.296350

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Flexible RSV prefusogenic fusion glycoprotein exposes multiple neutralizing epitopes that may collectively contribute to protective immunityDOI 10.1101/2020.09.14.296350Read

Alternative conformations of a major antigenic site on RSV FSemantic proximity Read

Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype BSemantic proximity Read

Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus.Semantic proximity Read

Functional implications of respiratory syncytial virus F sequence variability: a comparative analysis using contemporary RSV isolatesSemantic proximity Read

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism.Semantic proximity Read

A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responsesSemantic proximity Read

Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein.Semantic proximity Read

A tale of two fusion proteins: understanding the metastability of human respiratory syncytial virus and metapneumovirus and implications for rational design of uncleaved prefusion-closed trimersSemantic proximity Read

Generation of novel respiratory syncytial virus vaccine candidate antigens that can induce high levels of prefusion-specific antibodies.Semantic proximity Read

Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoproteinSemantic proximity Read

Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation.Semantic proximity Read

A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion proteinSemantic proximity Read